Melhem Solh on Muck Rack

Melhem Solh

As seen in: Nature, Healio, NewsBreak, Targeted Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Melhem

Contact Melhem, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia | Bone Marrow Transplantation

|
By Chenyu Lin, Matthew Connor, Navneet Majhail, Aaron Logan, Anjali Advani, LaQuisa C Hill, Joshua P. Sasine, Melhem Solh, Catherine Lee, Jessica Leonard, Marlise R. Luskin, Veronika Bachanova, Vinod Pullarkat, Ryan D. Cassaday, Lori Muffly, Jozal Moore
| Nature
Abstract Brexucabtagene autoleucel (brexu-cel) is a chimeric antigen receptor T (CAR T) cell therapy approved for adults with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL). We studied the impact of social determinants of health (SDoH) on outcomes of adults with B-ALL receiving brexu-cel. This retrospective analysis included adults (≥18 years) with R/R B-ALL treated with brexu-cel between 2021 and 2023.
Open in Who Shared Issue with article?

HLA evolutionary divergence (HED) informs the effect of HLA-B mismatch on outcomes after haploidentical transplantation - Bone Marrow Transplantation

|
By Melhem Solh
| Nature
Abstract Graft versus tumor relies on tumor-associated antigens (TAAs) that are presented to donor T cells via human leukocyte antigens (HLAs). The HLA evolutionary divergence (HED) between alleles of a single individual can dictate the ability to present TAAs. The impact of HED in haploidentical donor transplantation (HIDT) has not been studied. We studied the effect of HED on transplant outcomes following HIDT.
Open in Who Shared Issue with article?

Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients | Leukemia

|
By Talha Badar, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie Brown, Paul Castillo, Jan Černý, Charles Craddock, Bhagirathbhai Dholaria, Robert Peter Gale, Gerhard Hildebrandt, Mohamed A. Kharfan-Dabaja, Hillard M. Lazarus, Richard J. Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar Patel , Akshay Sharma, Melhem Solh, Trent Wang, Lena Winestone, Baldeep Mona Wirk, Christopher S Hourigan, Mark Litzow, Partow Kebriaei
| Nature
Correction to: Leukemia https://doi.org/10.1038/s41375-022-01738-3, published online 30 October 2022 In this article Wael Saber at affiliation Medical College of Wisconsin and Amer Zeidan at affiliation Bridgeport Hospital, Yale University School of Medicine were missing from the author list. The original article has been corrected.
Open in Who Shared Issue with article?
See all 9 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Melhem

Contact Melhem, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified